• 学术搜索
  • 科研智能体
    • Research Labs
    • AI 阅读
    • AI 文库
    • 深度研究
    • 学者亮点
  • 学术资源
    • AI2000
    • 期刊/会议
    • 学者库
    • 学术API
      MCP&Skill
    • 溯源树
    • 数据集
  • 知识沉淀
    • 学术空间
订阅小程序
旧版功能
aminer vip
开通会员低至0.73元/天
一次搞定AI科研
立即登录
  • English
  • 联系方式
    P

    Partners In Care

    49论文总数
    1,708引用总数

    论文量&引用量时间轴

    机构学者

    论文(49)

    年份
    起
    –
    止
    排序
    1Open-label Treatment Extension of Ruxolitinib Cream in Vitiligo: Findings from the Topical Ruxolitinib Evaluation in Vitiligo (True-V) Long-Term Extension Phase III Study.
    John E Harris,Kim Papp,Khaled Ezzedine,Michael Sebastian,Amit G Pandya,Julien Seneschal, Mark Amster, Maryam Shayesteh Alam,Seth B Forman,Jacek Zdybski, Anthony Nuara,Deanna Kornacki,

    We present data from the Topical Ruxolitinib Evaluation in Vitiligo (TRuE-V) long-term extension (LTE) study evaluating repigmentation outcomes with continued 1.5% ruxolitinib cream treatment in patients who did not achieve near-complete facial repigmentation in TRuE-V1/TRuE-V2. Among patients in the TRuE-V1/TRuE-V2 trials who applied ruxolitinib cream from day 1, approximately 66% achieved F-VASI 75 (indicative of treatment success) at week 104, increasing from nearly 31% at week 52 (TRuE-V LTE baseline); similar repigmentation improvements were reported in patients who switched from vehicle to ruxolitinib cream after TRuE-V1/TRuE-V2 at week 24, albeit with lower overall response rates due to the shorter duration of ruxolitinib cream application. These findings indicate that continued ruxolitinib cream treatment allows further repigmentation in many patients.

    2026The British journal of dermatology(2026)引用:2
    引用
    AI阅读
    加入学术空间
    2Falls in the Oldest Old: Role of Gender, Living Situation, and Assistive Devices.
    Katherine A Colcord,Luohua Jiang,Zarui A Melikyan, Zeinah Al-Darsani, Nikki Jagusch Arnold, Hayley B Kristinsson,Claudia H Kawas,María M Corrada

    INTRODUCTION:Falls can have serious health consequences, especially in the oldest old (individuals 90+ years), for whom falls often result in injury or even death. Few studies have examined falls in the oldest old. We aim to assess fall prevalence, fall rate, and rate change over time according to gender, living situation, and assistive device use. METHODS:Participants are from the 90+ Study, a longitudinal study of individuals 90 years and older with evaluations every 6 months. Participants, or their informants, were asked how many times they have fallen in the past year (first visit) or since their last visit (follow-up visits). We calculated unadjusted baseline fall prevalence. Using generalized linear mixed regression models, we estimated adjusted baseline fall rate and adjusted change in rate over time by gender, living situation, and assistive device. RESULTS:In 1,672 participants (mean age 93 years, range 90-110 years), unadjusted baseline prevalence of 1+ falls was 47.8% in women and 47.9% in men. Estimated adjusted baseline fall rate was 0.66 falls per person-year in women and 0.71 falls per person-year in men. In women, fall rate did not change significantly over time, whereas in men, fall rate increased by an average of 6% per year. Both men and women in nursing homes had a higher fall rate compared with those in the community. In nursing homes, fall rate remained stable over time in men and decreased over time in women. Fall rate was higher in both men and women using assistive devices. However, walkers were associated with a decrease in fall rate over time in women and in participants in nursing homes. Canes were unexpectedly associated with an increase in fall rate over time. CONCLUSION:Individuals 90 years and older had a high prevalence of falls overall. The higher and increasing rate of falls over time in men compared to women suggests that efforts should be made to increase the uptake of fall prevention strategies specifically in men in the oldest age categories. The increasing fall rate in participants using canes suggests that referral to a health care provider trained in gait analysis prior to assistive device prescription could assist with fall prevention efforts in the oldest old.

    2025Gerontology(2025)引用:1
    引用
    AI阅读
    加入学术空间
    3Exploring Heterogeneity in Determinants of Human Papillomavirus (HPV) Vaccination for Girls in Malawi
    Priya Sarma, Pericles Kalande, Helen Liang, Tahira Abu, Symon Chibaka, Khumbo Phiri, Amos Makwaya, Risa M. Hoffman,Sam Phiri,Corrina Moucheraud

    Malawi has the second-highest burden of cervical cancer globally and introduced the HPV vaccine in 2019 using a school-based model among 9-year-old girls—but vaccine uptake remains suboptimal. To design effective programs for increasing HPV vaccine uptake, it is necessary to understand differences across different groups. We sought to identify differences in parent-level factors hypothesized to affect girls’ HPV vaccination status, in order to inform subsequent vaccination promotion interventions. A household survey was conducted from December 2022 to January 2023 in three districts of Malawi with parents of girls aged 9–13 years. The interviewer-administered survey explored factors hypothesized to influence their daughters’ HPV vaccination status across the domains of HPV vaccination knowledge, attitudes, trust, social factors, and access. We described and compared attitudes and knowledge about the HPV vaccine between different sociodemographic groups (e.g., gender, educational attainment, employment status). A total of 299 parents completed the survey, and 39.0% reported their daughter(s) had received at least one dose of the HPV vaccine. Most parents agreed that vaccines are important and effective to protect their children’s health and stated more willingness to follow clinician recommendations for routine childhood vaccines than the HPV vaccine. We found some differences in vaccine attitudes by parent characteristic; for example, parents with secondary or higher education expressed more concerns about HPV vaccine safety and demonstrated lower HPV-related knowledge than their peers with less education (e.g., only 29.0% correctly identified that men can contract HPV compared to 67.3% of parents with no formal education); and women (79.4%) were more likely than men (63.2%) to report adherence to clinician recommendations for the HPV vaccine, as were unemployed parents (90.6%) compared to employed parents (74.4%). This analysis found differences in parent knowledge and attitudes toward HPV vaccination, based on education, gender, and employment status. Interestingly, highly educated parents expressed greater concerns about HPV vaccine safety and demonstrated lower HPV-related knowledge, suggesting that specific misinformation may be circulating within these communities. This highlights an important area for further investigation, as targeted interventions could improve HPV vaccine acceptance in Malawi. Priya Sarma, Pericles Kalande, Helen Liang, Tahira Abu, Symon Chibaka, Khumbo Phiri, Amos Makwaya, Risa M. Hoffman, Sam Phiri, Corrina Moucheraud. Exploring Heterogeneity in Determinants of Human Papillomavirus (HPV) Vaccination for Girls in Malawi [abstract]. In: Proceedings of the 13th Annual Symposium on Global Cancer Research; 2025 Sep 16. Philadelphia (PA): AACR; Cancer Epidemiol Biomarkers Prev 2025;34(12_Suppl):Abstract nr 55.

    2025CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION(2025)
    引用
    AI阅读
    加入学术空间
    4Top Ten Tips Palliative Care Clinicians Should Know about End-of-Life Doulas
    Erin F. Collins, Qwynn Galloway-Salazar, Elizabeth Johnson, Jennifer Blechman, Merilynne Rush, Emma Clare, Ashley Johnson, Aditi Sethi,William E. Rosa,Seiko Izumi

    Palliative care has made great strides in improving the lives of people living with serious illness, with an empirical premise for increasing quality, and sometimes quantity of life. Yet in some cases, there exist gaps that impede the ability of palliative care clinicians to truly advocate, procure, and provide the comprehensive services needed for patients, family caregivers, and communities, particularly in the contexts of caring for marginalized populations and working in under-resourced practice settings. The end-of-life doula role has emerged over the last decade and the availability of trained doulas in the community has burgeoned. An end-of-life doula is a nonmedical, holistic support person who provides education, guidance, emotional, spiritual, and practical support to persons and families navigating serious and terminal illness, ideally early in the disease process, throughout the time surrounding death, and during bereavement. A pervasive Western culture of avoiding the subject of death means that we, as a society, often do not know or remember how to navigate the journey of end of life in a way that is caring, compassionate, skilled, holistic, and centered on the needs and worldview of the dying one. The ten tips provided here can guide palliative care clinicians to leverage collaboration with trusted, community-based end-of-life doulas to ensure comprehensive and people-centered palliative care.

    2024JOURNAL OF PALLIATIVE MEDICINE(2024)引用:2
    引用
    AI阅读
    加入学术空间
    5Comment to a Survey of Healthcare Professionals' Perceptions of the Decisional Needs of Parents with an Infant Born with a Disorder/difference of Sex Development
    Kristina I. Suorsa-Johnson,Melissa D. Gardner,William Brinkman,Meg Carley,Larry Gruppen,Noi Liang,Sophie Lightfoot,Kendra Pinkelman,Phyllis W. Speiser,Brian VanderBrink,Jessica Wisniewski,David E. Sandberg,

    Introduction Parents of infants born with differences in sex development (DSD) face many difficult decisions. As part of a larger project designed to develop educational interventions to promote shared decision making, this study assessed healthcare professionals' (HCPs) perceptions of parental decision-making needs when an infant is born with a DSD. Methods A cross-sectional web-based survey following the Ottawa Decision Support Framework was conducted in two waves, between October 2020 and June 2022. Survey domains included: common DSD decisions, indicators of parents' decisional needs, and resources and approaches to support parental decision making. Eligible participants were HCPs working within interprofessional pediatric DSD centers in the USA. Up to three reminders were sent. Descriptive analysis was conducted. Results 71 HCPs participated; most (>90%) reported parents experience signs of decisional conflict including feeling unsure, worrying about what could go wrong, and fear of choosing a "wrong," irreversible option. The majority (90%) reported parents experience strong emotions interfering with their receptivity to information or deliberation. The majority (>70%) identified inadequate parental knowledge of the DSD as a barrier to decision making, coupled with information overload (>90%). HCPs rated several factors as "very" important, including: parents having information on benefits, harms, and other features of options (93%), having information about all the available options (87%), and having access to providers to discuss the options (84%). Providers endorsed using a variety of approaches to support parents' decision making; however, access to decision aids was not universally rated as highly important (very, 44%; somewhat, 46%; a little, 10%). Implications Overall, HCPs expressed favorable attitudes toward supporting active parental participation in medical decision making. Opportunities for enhanced support of shared decision making included: a) recognizing and addressing parental emotional distress and informational overload at a time when parents need to consider complex options for their infant or young child; and b) the need for HCPs to encourage values clarification in decision-making encounters with parents.

    2023JOURNAL OF PEDIATRIC UROLOGY(2023)引用:6
    引用
    AI阅读
    加入学术空间
    立即登录,查看全部 49 篇论文

    合作机构(52)

    American Association of Nurse Practitioners合作论文 2
    港加大学医学中心合作论文 2
    麻省大学医学院合作论文 1
    密歇根大学合作论文 1
    哈佛大学合作论文 1
    贝斯以色列女执事医疗中心合作论文 1
    东京大学合作论文 1
    Barrie Urology Group合作论文 1
    Partners In Health合作论文 1
    渥太华大学(美国)合作论文 1

    机构统计